Director Shareholding
21 May 2003 - 5:01PM
UK Regulatory
RNS Number:3555L
Keryx Biopharmaceuticals Inc
20 May 2003
Keryx Biopharmaceuticals, Inc ("the Company")
The Company was notified today that on the 15 May 2003 1,000,000 shares of
common stock held in trust for Lindsay A Rosenwald's minor children was sold. Dr
Rosenwald does not act as a trustee.
Following this transaction Dr. Rosenwald has a direct interest in 3,015,123
shares and an indirect interest in 2,568,787 shares representing 26.8% of the
issued share capital of the Company.
20 May 2003
Contact:
Mr Bob Trachtenberg
General Counsel, Keryx Biopharmaceuticals, Inc.
Tel: 00 972 2541 3500
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSVBLFLXEBEBBE